Pathology

Medicine & Life Sciences

1. Activating Transcription Factor 3 16%
2. Acute Myeloid Leukemia 25%
3. Adenocarcinoma 17%
4. African Americans 11%
5. Antibodies 14%
6. Apoptosis 15%
7. B-Lymphocytes 10%
8. Biomarkers 11%
9. Biopsy 19%
10. Blood Proteins 14%
11. Bone and Bones 18%
12. Bone Marrow 11%
13. Brain 13%
14. Breast Neoplasms 31%
15. Carcinogenesis 18%
16. Carcinoma 22%
17. Cell Line 17%
18. Cell Movement 15%
19. Cell Proliferation 13%
20. Chromosome Mapping 21%
21. Chromosomes 14%
22. Colonic Neoplasms 14%
23. Colorectal Neoplasms 16%
24. Comparative Genomic Hybridization 13%
25. Dendritic Cells 13%
26. DNA 11%
27. DNA Methylation 9%
28. Down-Regulation 12%
29. Drug Therapy 10%
30. Electrophoresis 19%
31. Enzymes 9%
32. Gastric Inhibitory Polypeptide 24%
33. Gene Expression 16%
34. Genes 50%
35. Genome 11%
36. Glioblastoma 22%
37. Glioma 19%
38. Growth 20%
39. Heart 11%
40. Histology 9%
41. Immunoglobulins 10%
42. Immunotherapy 10%
43. In Vitro Techniques 15%
44. Indoleamine-Pyrrole 2,3,-Dioxygenase 36%
45. Inflammation 14%
46. Kidney 21%
47. Leucine 10%
48. Leukemia 35%
49. Light 20%
50. Loss of Heterozygosity 14%
51. Lung 26%
52. Lung Neoplasms 9%
53. Lymph Nodes 15%
54. Lymphoma 34%
55. Mass Spectrometry 10%
56. Melanoma 12%
57. Meningioma 12%
58. Mesenchymal Stem Cells 10%
59. MicroRNAs 23%
60. Multiple Myeloma 16%
61. Mutation 20%
62. Myeloid Cells 9%
63. Myeloid-Derived Suppressor Cells 12%
64. Myeloproliferative Disorders 10%
65. Necrosis 10%
66. Neoplasm Metastasis 42%
67. Neoplasms 100%
68. Neoplastic Stem Cells 12%
69. Neuroblastoma 12%
70. Pathologists 14%
71. Pathology 22%
72. Pediatrics 16%
73. Phenotype 19%
74. Phospholipase D 10%
75. Phosphotransferases 26%
76. Prostate 11%
77. Prostatic Neoplasms 18%
78. Proteins 27%
79. Radiation 10%
80. Receptor, Fibroblast Growth Factor, Type 1 28%
81. Renal Cell Carcinoma 14%
82. SARS Virus 13%
83. Seizures 10%
84. Serum 18%
85. Single Nucleotide Polymorphism 10%
86. spasmolytic polypeptide 15%
87. Squamous Cell Carcinoma 11%
88. Staining and Labeling 16%
89. Stem Cells 32%
90. Surgical Pathology 11%
91. Survival 26%
92. T-Lymphocytes 25%
93. Therapeutics 23%
94. Tissue Inhibitor of Metalloproteinase-1 10%
95. Transplants 11%
96. Type 1 Diabetes Mellitus 9%
97. Up-Regulation 13%
98. Urinary Bladder Neoplasms 22%
99. Wiskott-Aldrich Syndrome Protein Family 10%
100. Zebrafish 12%